Seasonal Allergic Rhinitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2007-06-19
Clinical Trial Update: A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions
A completed pilot monocenter trial evaluating cellular and soluble biomarkers in nasal secretions from participants with seasonal allergic r…
FDA approval · 2007-04-27
FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Original Application (Haleon US Holdings LLC)
FDA approved FLONASE SENSIMIST ALLERGY RELIEF (fluticasone furoate) under an original NDA from Haleon US Holdings LLC for relief of symptoms…
FDA label_change · 2007-04-13
FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the drug's labelin…
FDA approval · 2007-04-13
FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
CLINICAL_TRIALS trial_result · 2007-03-06
Clinical Trial Update: Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis [Phase 1, Phase 2]
Phase I/IIa clinical trial evaluating chitin microparticles for seasonal allergic rhinitis has completed. No efficacy results are provided i…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2007-01-26
Clinical Trial Update: Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis [NA]
A completed clinical trial investigated the effects of orotic acid derivatives with or without glutathione on seasonal allergic rhinitis. Th…
CLINICAL_TRIALS research · 2006-10-18
Clinical Trial Update: Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 [Phase 2, Phase 3]
Clinical trial update on using probiotic bacteria to prevent allergic diseases in children, spanning Phase 2 and Phase 3.
FDA approval · 2006-05-19
FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC, resulting in labeling modifications related to its indic…
FDA approval · 2006-05-19
FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.